Category: Myeloma & Amyloidosis

CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support

Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO and Jay Spiegel, MD, Sylvester Comprehensive Cancer Center, Miami, FL

Optimizing Outcomes in Myeloma

Amy Pierre, MSN, ANP-BC, Flatiron Health and Memorial Sloan Kettering, New York, NY and Peter Voorhees, MD, Levine Cancer Institute, Charlotte, NC

Key Insights from Attending ASH 2025

Lore Gruenbaum, PhD, Blood Cancer United, Washington, DC

Navigating Complex and Challenging Cases in Myeloma

Angela Dispenzieri, MD, Mayo Clinic, Rochester, MN

CAR-T in 2025: Advancements and the Road Ahead

Jason Westin, M.D., MS, FACP, MD Anderson Cancer Center, Houston, TX

Highlights from Attending ASH 2024

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

Scroll to Top